Alpine Immune Sciences, Inc.
(Deutsche Boerse AG : NVLS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.14%191.811.2%$561.99m
GILDGilead Sciences, Inc.
0.35%71.170.9%$497.50m
BIIBBiogen Inc.
-0.70%316.841.3%$445.41m
CELGCelgene Corporation
-0.23%70.081.2%$417.46m
ILMNIllumina, Inc.
0.08%311.443.5%$398.62m
REGNRegeneron Pharmaceuticals, Inc.
-0.70%339.692.6%$279.79m
VRTXVertex Pharmaceuticals Incorporated
-2.57%165.941.9%$264.38m
ALXNAlexion Pharmaceuticals, Inc.
-1.16%117.142.0%$196.75m
AAgilent Technologies, Inc.
-0.65%63.921.5%$167.05m
EXASExact Sciences Corporation
-0.53%69.0425.3%$148.86m
LGNDLigand Pharmaceuticals Incorporated
0.34%148.9423.3%$144.10m
SRPTSarepta Therapeutics, Inc.
-2.99%113.2716.4%$129.58m
ECYTEndocyte, Inc.
-0.06%23.572.0%$120.21m
INCYIncyte Corporation
1.21%64.502.5%$113.75m
BMRNBioMarin Pharmaceutical Inc.
-1.39%92.224.3%$108.32m

Company Profile

Alpine Immune Sciences, Inc. is a development-stage pharmaceutical company, which engages in the discovering of protein-based immunotherapies therapies targeting the immune synapse to treat cancer, autoimmune, and inflammatory disorders. It offers Immunotherapy, Immune Synapse, vIgD Platform Technology, and TIP Program. The company was founded on July 24, 2017 and is headquartered in Seattle, WA.